Miro Bakula
Overview
Explore the profile of Miro Bakula including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Petrinovic M, Majetic D, Bakula M, Pecin I, Fabris-Vitkovic D, Deskin M, et al.
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39408705
According to recent data, one in eight people in the world struggle with obesity. Obesity management is increasingly dependent on bariatric surgical interventions, as the combination of lifestyle modifications and...
2.
Gradinjan Centner M, cacic Kenjeric D, Schonberger E, Centner H, Sladic Rimac D, Steiner K, et al.
Life (Basel)
. 2024 Sep;
14(9).
PMID: 39337936
Type 1 diabetes has become prevalent among the adult population, who have increasingly gained access to sensing technology. This study delved into the impact of diet, nutritional status, and the...
3.
Medic F, Bakula M, Alfirevic M, Bakula M, Mucic K, Maric N
Acta Clin Croat
. 2023 Feb;
61(2):327-341.
PMID: 36818930
Thyroid gland has a key role in maintaining the body homeostasis. Thyroxine is the main hormone secreted from the thyroid gland, its effect being predominantly achieved after the intracellular conversion...
4.
Maric N, Mackovic M, Bakula M, Mucic K, Udiljak N, Marusic M
Clin Endocrinol (Oxf)
. 2021 Jul;
96(2):139-143.
PMID: 34263462
Objective: There are no definitive treatment guidelines for hypertriglyceridemia (HTG)-induced acute pancreatitis (AP). The aim of this retrospective study was to evaluate the efficacy of insulin in decreasing triglyceride (TG)...
5.
Liberati-cizmek A, Bilus M, Lovro Brkic A, Colic Baric I, Bakula M, Hozic A, et al.
Plant Foods Hum Nutr
. 2019 Apr;
74(2):235-240.
PMID: 30993530
Metabolic syndrome, characterized by obesity, low-grade inflammation, insulin resistance, hyperglycemia, dyslipidemia and hypertension, is a major risk factor for cardiovascular mortality. Preclinical studies on recently discovered classes of lipids -...
6.
Skelin M, Lucijanic T, Liberati-cizmek A, Klobucar S, Lucijanic M, Jakupovic L, et al.
Endocrine
. 2018 Jul;
62(2):432-439.
PMID: 30043093
Aim: Hypothyroidism is a common clinical problem that is successfully treated with hormone substitutes in the form of levothyroxine (LT4). LT4 is a drug with a narrow therapeutic index and...
7.
Skelin M, Lucijanic T, Amidzic Klaric D, Resic A, Bakula M, Liberati-cizmek A, et al.
Clin Ther
. 2017 Feb;
39(2):378-403.
PMID: 28153426
Purpose: Levothyroxine (LT4) is a drug with a narrow therapeutic index, applied in small amounts (micrograms), which makes interactions in the absorption phase clinically significant. The main aim of this...
8.
Rahelic D, Altabas V, Bakula M, Balic S, Balint I, Markovic B, et al.
Lijec Vjesn
. 2016 Jul;
138(1-2):1-21.
PMID: 27443001
Introduction: The Croatian Association for Diabetes and Metabolic Disorders of the Croatian Medical Association has issued in 2011 the first national guidelines for the nutrition, education, self-control, and pharmacotherapy of...
9.
Bakula M, Milicevic G, Bakula M, Kozic I, Rumenjak V, Dominkovic A
Clin Lab
. 2016 May;
62(4):563-71.
PMID: 27215074
Background: Ischemia-modified albumin (IMA) is a potentially valuable biochemical marker of myocardial ischemia. The aim of our study was to define the kinetics and to determine the diagnostic value of...
10.
Vlak T, Kastelan D, Lozo P, Aljinovic J, Gradiser M, Mijic S, et al.
Clin Rheumatol
. 2011 Sep;
30(12):1549-54.
PMID: 21956235
A prospective, open-labelled, multicentre 6-month study was designed to assess three categories that have high impact on Health-Related Quality of Life (HR-QoL). These categories were: satisfaction, preference and drug tolerability...